Purchase Order 75N93021P01302

This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Stemcell Technologies Inc. for EASYSEP NEGATIVE HUMAN CD4 KITS. The $59,775.00 contract has a completion date of July 31, 2019 and was awarded on July 19, 2018 with no set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which...

The National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS), awarded a $80,536.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc. for EasySep Negative Human CD4 and CD8 Kits. This contract does not have a set-aside designation. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research...

This is a $17,134.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of EasySep Negative Human CD4 Kits, which are used in cell separation and cell culture applications to support biomedical research. The contract is a Blanket Purchase Agreement (BPA) call, meaning it is part of a larger indefinite...

This is a firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of the EasySep Human Pan-B Cell Enrichment Kit, a specialized cell separation product used to support biomedical research initiatives. The contract has a ceiling value of...

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of the "EasySep Negative Human NK, 1 mL" product, which is a cell separation system used in stem cell research, immunology, and infectious...

This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,670.00 firm fixed price purchase order to Stemcell Technologies Inc., a Canadian-owned for-profit company, for CD4 EASYSEP NEGATIVE SELECTION KITS. This award was not set aside for any particular business type. Stemcell Technologies Inc. is an experienced federal contractor that frequently provides specialized biological materials, lab supplies, scientific...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $100,836.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit company, to provide EASYSEP ENRICHMENT KITS. This contract has a performance period from July 5, 2017 to July 5, 2018 and was not set aside for a particular type of small business. Stemcell Technologies Inc. is an established federal contractor...

This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Stemcell Technologies Inc., a Canadian-owned for-profit organization, on August 6, 2019. The $24,069.90 contract is for the delivery of EasySep Negative Human CD4 Kits and EasySep Negative Human CD8 Kits, which are specialized biological products used in life sciences research. This sole-source award was made under the authority of 41 U.S.C....